These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3931959)

  • 21. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacterial infections of the lungs in mucoviscidosis patients].
    Hogardt M; Heesemann J
    MMW Fortschr Med; 2005 Jan; 147(4):38-40. PubMed ID: 15745340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
    Le Roux P; Le Luyer B
    Arch Pediatr; 2003 Sep; 10 Suppl 2():358s-363s. PubMed ID: 14671935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized antibiotics in cystic fibrosis: current and future trends.
    Fiel SB
    Expert Rev Respir Med; 2008 Aug; 2(4):479-87. PubMed ID: 20477211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient medication costs of patients with cystic fibrosis in Germany.
    Eidt-Koch D; Wagner TO; Mittendorf T; Graf von der Schulenburg JM
    Appl Health Econ Health Policy; 2010; 8(2):111-8. PubMed ID: 20175589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic use in cystic fibrosis.
    Kelly HW; Lovato C
    Drug Intell Clin Pharm; 1984 Oct; 18(10):772-83. PubMed ID: 6435985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.
    Charrier C; Rodger C; Robertson J; Kowalczuk A; Shand N; Fraser-Pitt D; Mercer D; O'Neil D
    Orphanet J Rare Dis; 2014 Nov; 9():189. PubMed ID: 25433388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic treatment of CF lung disease: from bench to bedside.
    Bals R; Hubert D; Tümmler B
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S146-51. PubMed ID: 21658633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbations in cystic fibrosis: 2 . prevention.
    Bell SC; Robinson PJ
    Thorax; 2007 Aug; 62(8):723-32. PubMed ID: 17687099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic therapies in cystic fibrosis. Does standard therapy work?
    Marshall BC; Samuelson WM
    Clin Chest Med; 1998 Sep; 19(3):487-504, vi. PubMed ID: 9759551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical evaluation of bronchial hygiene in pediatric pulmonary disease.
    Holsclaw DS; Tecklin JS
    Pediatr Ann; 1977 Aug; 6(8):550-6. PubMed ID: 896310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis: a review of pathophysiology and current treatment recommendations.
    Peters S
    S D Med; 2014 Apr; 67(4):148-51, 153. PubMed ID: 24791377
    [No Abstract]   [Full Text] [Related]  

  • 36. Respiratory Conditions Update: Cystic Fibrosis.
    Pritchard LL
    FP Essent; 2016 Sep; 448():35-43. PubMed ID: 27576234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CYSTIC FIBROSIS: CARE OF THE LUNG DISEASE].
    Hubert D
    Rev Prat; 2015 Oct; 65(8):1095-9. PubMed ID: 26749716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototype.
    Kearns GL; Trang JM
    J Pediatr; 1986 May; 108(5 Pt 2):847-53. PubMed ID: 3517272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
    Lindsay CA; Bosso JA
    Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.
    Horrevorts AM; Driessen OM; Michel MF; Kerrebijn KF
    Chest; 1988 Aug; 94(2 Suppl):120S-125S. PubMed ID: 3293937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.